4lts
From Proteopedia
(Difference between revisions)
(3 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
+ | |||
==Discovery of Potent and Efficacious Cyanoguanidine-containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors== | ==Discovery of Potent and Efficacious Cyanoguanidine-containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors== | ||
- | <StructureSection load='4lts' size='340' side='right' caption='[[4lts]], [[Resolution|resolution]] 1.69Å' scene=''> | + | <StructureSection load='4lts' size='340' side='right'caption='[[4lts]], [[Resolution|resolution]] 1.69Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4lts]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4lts]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LTS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4LTS FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=LTS:2-CYANO-1-PYRIDIN-4-YL-3-(4-{[3-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}BENZYL)GUANIDINE'>LTS</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.692Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=LTS:2-CYANO-1-PYRIDIN-4-YL-3-(4-{[3-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}BENZYL)GUANIDINE'>LTS</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4lts FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lts OCA], [https://pdbe.org/4lts PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4lts RCSB], [https://www.ebi.ac.uk/pdbsum/4lts PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4lts ProSAT]</span></td></tr> | |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/NAMPT_HUMAN NAMPT_HUMAN] Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway (By similarity). |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 19: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 4lts" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
- | *[[Phosphoribosyltransferase|Phosphoribosyltransferase]] | + | *[[Phosphoribosyltransferase 3D structures|Phosphoribosyltransferase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: Bair | + | [[Category: Bair KW]] |
- | [[Category: Baumeister | + | [[Category: Baumeister T]] |
- | [[Category: Buckmelter | + | [[Category: Buckmelter AJ]] |
- | [[Category: Caligiuri | + | [[Category: Caligiuri M]] |
- | [[Category: Clodfelter | + | [[Category: Clodfelter KH]] |
- | [[Category: Dragovich | + | [[Category: Dragovich PS]] |
- | [[Category: Han | + | [[Category: Han B]] |
- | [[Category: Ho | + | [[Category: Ho Y]] |
- | [[Category: Kley | + | [[Category: Kley N]] |
- | [[Category: Lin | + | [[Category: Lin J]] |
- | [[Category: Oh | + | [[Category: Oh A]] |
- | [[Category: Reynoids | + | [[Category: Reynoids DJ]] |
- | [[Category: Sharma | + | [[Category: Sharma G]] |
- | [[Category: Smith | + | [[Category: Smith CC]] |
- | [[Category: Wang | + | [[Category: Wang L]] |
- | [[Category: Wang | + | [[Category: Wang W]] |
- | [[Category: Wang | + | [[Category: Wang Z]] |
- | [[Category: Yuen | + | [[Category: Yuen P]] |
- | [[Category: Zak | + | [[Category: Zak M]] |
- | [[Category: Zheng | + | [[Category: Zheng X]] |
- | + | ||
- | + |
Current revision
Discovery of Potent and Efficacious Cyanoguanidine-containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors
|
Categories: Homo sapiens | Large Structures | Bair KW | Baumeister T | Buckmelter AJ | Caligiuri M | Clodfelter KH | Dragovich PS | Han B | Ho Y | Kley N | Lin J | Oh A | Reynoids DJ | Sharma G | Smith CC | Wang L | Wang W | Wang Z | Yuen P | Zak M | Zheng X